FAM161B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.009800E-01
Normal-vs-Stage2
4.549600E-01
Normal-vs-Stage3
4.340000E-01
Normal-vs-Stage4
5.376200E-02
Stage1-vs-Stage2
1.395420E-01
Stage1-vs-Stage3
2.803800E-02
Stage1-vs-Stage4
9.384400E-02
Stage2-vs-Stage3
1.738970E-01
Stage2-vs-Stage4
3.98820000000466E-05
Stage3-vs-Stage4
4.856100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.373600E-01
Normal-vs-AfricanAmerican
5.093200E-01
Normal-vs-Asian
7.814400E-01
Caucasian-vs-AfricanAmerican
6.810000E-01
Caucasian-vs-Asian
3.144000E-01
AfricanAmerican-vs-Asian
7.208800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.215600E-01
Normal-vs-Female
4.779200E-01
Male-vs-Female
8.308200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.344010E-01
Normal-vs-Age(41-60Yrs)
2.242200E-01
Normal-vs-Age(61-80Yrs)
5.763400E-01
Normal-vs-Age(81-100Yrs)
5.059800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.613000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.533000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.269200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.465500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.637600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.899000E-01
Normal-vs-Daily Drinker
6.291800E-01
Normal-vs-Weekly Drinker
6.360200E-01
Normal-vs-Occasional Drinker
2.481200E-01
Normal-vs-Social Drinker
4.710000E-01
Non Drinker-vs-Daily Drinker
5.101000E-01
Non Drinker-vs-Weekly Drinker
6.137200E-01
Non Drinker-vs-Occasional Drinker
2.722100E-02
Non Drinker-vs-Social Drinker
2.336800E-01
Daily Drinker-vs-Weekly Drinker
8.778600E-01
Daily Drinker-vs-Occasional Drinker
1.185590E-01
Daily Drinker-vs-Social Drinker
4.791800E-01
Weekly Drinker-vs-Occasional Drinker
1.179410E-01
Weekly Drinker-vs-Social Drinker
4.366600E-01
Occasional Drinker-vs-Social Drinker
5.090200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.916400E-01
Normal-vs-Grade 2
6.174200E-02
Normal-vs-Grade 3
5.765700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.937200E-01
Grade 1-vs-Grade 3
7.036800E-01
Grade 1-vs-Grade 4
2.916400E-01
Grade 2-vs-Grade 3
5.254200E-01
Grade 2-vs-Grade 4
6.174200E-02
Grade 3-vs-Grade 4
5.765700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.572800E-01
Normal-vs-NonDiabetic
5.013400E-01
Diabetic-vs-NonDiabetic
6.545800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.805200E-01
Normal-vs-NoPancreatitis
4.811600E-01
Pancreatitis-vs-NoPancreatitis
3.131700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.414600E-01
Normal-vs-N1
4.486600E-01
N0-vs-N1
2.288000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.801600E-01
Normal-vs-TP53-NonMutant
1.167920E-02
TP53-Mutant-vs-TP53-NonMutant
6.675800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
